25.34
0.16%
0.0413
Xoma Corporation stock is traded at $25.34, with a volume of 201.
It is up +0.16% in the last 24 hours and up +0.48% over the past month.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
See More
Previous Close:
$25.30
Open:
$25.3346
24h Volume:
201
Relative Volume:
0.08
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.03%
1M Performance:
+0.48%
6M Performance:
-1.28%
1Y Performance:
+2.06%
Xoma Corporation Stock (XOMAO) Company Profile
Name
Xoma Corporation
Sector
Industry
Phone
510 204 7200
Address
2200 Powell Street, Suite 310, EmeryVille
Compare XOMAO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
XOMAO
Xoma Corporation
|
25.33 | 0 | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
487.98 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
716.13 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
667.55 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
274.45 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
122.44 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xoma Corporation Stock (XOMAO) Latest News
HC Wainwright Has Lowered Expectations for XOMA (NASDAQ:XOMA) Stock Price - Defense World
StockNews.com Downgrades XOMA (NASDAQ:XOMA) to Sell - Defense World
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire
Exclusive Healthcare Insights: XOMA Leadership Takes Center Stage at Oppenheimer Conference - StockTitan
XOMA (NASDAQ:XOMAP) Trading Up 0.4% – Should You Buy? - Defense World
XOMA stock price target cut to $104 by H.C. Wainwright - MSN
Forecasting The Future: 5 Analyst Projections For XOMA Royalty - Benzinga
XOMA (NASDAQ:XOMA) Price Target Lowered to $104.00 at HC Wainwright - MarketBeat
XOMA Co. (NASDAQ:XOMA) Major Shareholder Sells $13,069,366.20 in Stock - MarketBeat
Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 34.2% - Defense World
Xoma royalty corp sees sale of $16.98 million in stock by investors - MSN
How to Take Advantage of moves in (XOMA) - Stock Traders Daily
BIOTECHNOLOGY VALUE FUND L P Reduces Stake in XOMA Royalty Corp - GuruFocus.com
Xoma royalty corp sees sale of $16.98 million in stock by investors By Investing.com - Investing.com India
Barclays PLC Has $298,000 Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
How To Trade (XOMAP) - Stock Traders Daily
(XOMAO) Proactive Strategies - Stock Traders Daily
XOMA (NASDAQ:XOMA) Upgraded at StockNews.com - MarketBeat
XOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.com - Defense World
XOMA Royalty Corporation: High-Risk Royalty Aggregator Best Avoided - Seeking Alpha
XOMA (NASDAQ:XOMA) and Oragenics (NYSE:OGEN) Head to Head Review - Defense World
Xoma Royalty's chief investment officer buys $13,974 in stock By Investing.com - Investing.com Australia
XOMA (NASDAQ:XOMAP) Trading Down 0.8% – Here’s Why - Defense World
Long Term Trading Analysis for (XOMAP) - Stock Traders Daily
XOMA (NASDAQ:XOMA) Earns “Buy” Rating from HC Wainwright - Defense World
XOMA shares gain momentum, analyst notes 10%+ revenue growth potential from RZ358 By Investing.com - Investing.com South Africa
XOMA shares gain momentum, analyst notes 10%+ revenue growth potential from RZ358 - Investing.com
How to Take Advantage of moves in (XOMAO) - Stock Traders Daily
Trend Tracker for (XOMA) - Stock Traders Daily
XOMA (NASDAQ:XOMA) Downgraded by StockNews.com to Sell - MarketBeat
HC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA) - MarketBeat
Barclays PLC Acquires 8,447 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
Geode Capital Management LLC Purchases 1,138 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
State Street Corp Has $3.78 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
(XOMAP) Investment Report - Stock Traders Daily
Short Interest in XOMA Co. (NASDAQ:XOMAO) Grows By 26.7% - Defense World
XOMA Co. (NASDAQ:XOMA) Sees Significant Growth in Short Interest - Defense World
XOMA (NASDAQ:XOMA) Lowered to “Sell” Rating by StockNews.com - Defense World
XOMA (NASDAQ:XOMA) Lowered to "Sell" Rating by StockNews.com - MarketBeat
BNP Paribas Financial Markets Purchases 795 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
Trading (XOMAP) With Integrated Risk Controls - Stock Traders Daily
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends for Series A and B Shares - StockTitan
Objective long/short (XOMAO) Report - Stock Traders Daily
Long Term Trading Analysis for (XOMA) - Stock Traders Daily
Biodefense Market CAGR of 7.3% Size, Growth Drivers and Forecast 2024-2031 | XOMA corporation, Altimmune Inc., - EIN News
XOMA (NASDAQ:XOMA) Earns Buy Rating from HC Wainwright - Defense World
XOMA (NASDAQ:XOMAP) Trading Down 0.6% – Should You Sell? - Defense World
XOMA (NASDAQ:XOMA) Receives Buy Rating from HC Wainwright - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
Xoma to take delivery of process water for testing - Marketscreener.com
Xoma Corporation Stock (XOMAO) Financials Data
There is no financial data for Xoma Corporation (XOMAO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Cap:
|
Volume (24h):